PhAsIca operates at the intersection of physics, artificial intelligence, and clinical oncology, anchored by a strategic collaboration with Hospital Clínico San Carlos — one of Spain’s leading academic medical centers.

This partnership embeds our platform directly within the translational environment where computational discoveries become real therapies. Together, we pursue multi-center oncology research, real-world clinical studies, and patient-centered treatment optimization, continuously grounding our science in clinical reality. Through Hospital Clínico San Carlos’s established networks across European hospitals and universities, PhAsIca accesses the academic and clinical ecosystems that accelerate the path from bench to bedside.

On the computational side, we jointly explore AI-assisted drug discovery, predictive patient stratification, and high-performance computing infrastructure — creating direct feedback loops between simulation and clinical validation. These collaborations ensure that every model we build is sharpened by real oncological data and world-class clinical expertise.

Beyond science, PhAsIca is building a living global network of researchers, clinicians, and innovators across Spain, Europe, China, Hong Kong, and beyond. We co-organize expert exchanges, research internships, clinical training programs, and international workshops that connect talent across continents and institutions.

This global academic infrastructure accelerates our science while positioning our partners as internationally recognized hubs of oncology innovation. PhAsIca is not just a biotech company — it is a platform for translational research, computational discovery, and global scientific collaboration.